Cargando…
Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy
Fetal growth restriction (FGR) in pregnancy is commonly caused by impaired uteroplacental blood flow. Vasodilators enhance uteroplacental perfusion and fetal growth in humans and animal models; however, detrimental maternal and fetal side effects have been reported. We hypothesised that targeted ute...
Autores principales: | Cureton, Natalie, Korotkova, Iana, Baker, Bernadette, Greenwood, Susan, Wareing, Mark, Kotamraju, Venkata R, Teesalu, Tambet, Cellesi, Francesco, Tirelli, Nicola, Ruoslahti, Erkki, Aplin, John D, Harris, Lynda K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667343/ https://www.ncbi.nlm.nih.gov/pubmed/29109771 http://dx.doi.org/10.7150/thno.19678 |
Ejemplares similares
-
Tumor-homing peptides as tools for targeted delivery of payloads to the placenta
por: King, Anna, et al.
Publicado: (2016) -
Tumor-Penetrating Peptides
por: Teesalu, Tambet, et al.
Publicado: (2013) -
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
por: Scodeller, Pablo, et al.
Publicado: (2017) -
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
por: Hurtado de Mendoza, Tatiana, et al.
Publicado: (2021) -
Sildenafil citrate and uteroplacental perfusion in fetal growth restriction
por: Dastjerdi, Marzieh Vahid, et al.
Publicado: (2012)